Unveiling 8 Analyst Insights On Corcept Therapeutics
Unveiling 8 Analyst Insights On Corcept Therapeutics
揭示corcept医疗的8个分析师见解
Corcept Therapeutics (NASDAQ:CORT) underwent analysis by 8 analysts in the last quarter, revealing a spectrum of viewpoints from bullish to bearish.
过去一个季度，8位分析师对Corcept Therapeutics (NASDAQ:CORT)进行了分析，从看好到看淡，看法不一。
In the table below, you'll find a summary of their recent ratings, revealing the shifting sentiments over the past 30 days and comparing them to the previous months.
在下表中，您将找到他们最近的评级摘要，揭示了过去30天内情绪的变化，并将它们与前几个月进行比较。
Providing deeper insights, analysts have established 12-month price targets, indicating an average target of $46.5, along with a high estimate of $65.00 and a low estimate of $35.00. This upward trend is evident, with the current average reflecting a 9.72% increase from the previous average price target of $42.38.
更深入的洞察表明，分析师已经给出了12个月的股价目标，平均目标为46.5美元，高估值为65.00美元，低估值为35.00美元。这种上涨趋势非常明显，当前平均价格比上一个平均目标价格42.38美元增长了9.72%。
Decoding Analyst Ratings: A Detailed Look
分析师评级解读：详细解析
An...
对...
登录免费看全文
登录/注册